Primary sclerosing cholangitis and cholangiocarcinoma: the 2023 practice guidance and future perspectives
- PMID: 38322224
- PMCID: PMC10839724
- DOI: 10.21037/hbsn-23-621
Primary sclerosing cholangitis and cholangiocarcinoma: the 2023 practice guidance and future perspectives
Keywords: American Association for the Study of Liver Diseases (AASLD); biliary cancer; guidelines; liver cancer; primary sclerosing cholangitis (PSC).
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-23-621/coif). The authors have no conflicts of interest to declare.
Comment on
- Hepatology. 77:659.
References
Publication types
LinkOut - more resources
Full Text Sources